Magnetic Resonance Imaging

The International Society of Magnetic Resonance in Medicine awarded Natalie J. Serkova, PhD, the 2021 Senior Fellow Award for her work in animal imaging for oncology research.

Combining an MRI-targeted biopsy approach with the Stockholm3 blood test for prostate cancer screening reduced overdetection while still identifying significant cancer, according to results of the randomized, population-based STHLM3MRI trial.

A novel cardiac MRI technology greatly reduced the amount of time it takes for a scan, potentially lifting a barrier to use, researchers reported.

Links between clinical and imaging variables and stroke recurrence in patients with intracranial atherosclerotic disease and recent stroke or transient ischemic attack.

Cardiology Today Editorial Board Member Nathaniel Reichek, MD, FAHA, FACC, a pioneer in the development and use of cardiac MRI, recently died, the Society for Cardiac Magnetic Resonance announced.

The FDA approved expanded labeling for Medtronic’s InterStim II and InterStim Micro sacral neuromodulation systems that use SureScan MRI leads, enabling a broader range of MRI scan parameters, according to a press release from the company.

A new study suggests that MRI testing could be used to detect prostate cancer. It was the top story in hematology/oncology last week.

MRI improved detection of clinically significant prostate cancer without increasing overdiagnosis compared with PSA testing, according to a prospective, population-based, blinded cohort study published in JAMA Oncology.

Non-Hispanic Black and Hispanic children were less likely to undergo radiography, CT, ultrasonography and an MRI during ED visits than non-Hispanic white children, an analysis of more than 13 million ED visits showed.

Multiparametric MRI often underestimated pathological tumor size among men with biopsy-proven prostate cancer, according to single-arm study results published in Journal of Urology.